AthenaVita Resource Library
Understanding Your PREVENT Risk Estimate
A risk estimate helps you and your clinician discuss prevention. It does not diagnose heart disease or predict exactly what will happen to you.
What PREVENT estimates
The AHA PREVENT equations use cardiovascular, kidney, and metabolic measures to estimate future cardiovascular risk. Outputs can include total cardiovascular disease, atherosclerotic cardiovascular disease, and heart failure. Check which outcome and time horizon you are looking at; percentages for different outcomes are not interchangeable.
Check which estimate you are reading.
| Question | What to verify |
|---|---|
| Outcome | Total cardiovascular disease, atherosclerotic cardiovascular disease, or heart failure. |
| Time horizon | Which supported period the displayed percentage describes. |
| Inputs | Accurate, dated results and treatment information; do not invent missing values. |
| Context | Relevant personal history and inherited risk discussed alongside the estimate. |
Who the tool is for
It is designed for primary prevention in adults ages 30–79 without known cardiovascular disease. The available long-term estimate depends on age and the calculator's supported range. If you already have cardiovascular disease, a primary-prevention score is not the basis of your treatment plan.
Use accurate, dated information
Your clinician needs age, cholesterol results, blood pressure, body size, kidney function, diabetes and smoking status, and relevant treatment information. Some versions support additional predictors such as A1c and urine albumin. Do not invent missing values or treat an old laboratory result as current.
Translate the percentage
For illustration, a 5% estimate describes about five events among 100 comparable people over the specified period. It does not mean you have a 5% blockage or that a particular symptom is safe. A shorter-term estimate can be low while longer-term prevention still matters.
Add the information the score does not fully capture
Pregnancy complications, menopause timing, inherited lipid risk, family history, and other clinical details may change the discussion. Ask your clinician which factors belong alongside the calculated result. The estimate supports shared decisions; it does not replace them.
Ask what changes because of the result
Which daily changes or treatments are worth prioritizing? Does the estimate support a medication discussion? Would additional testing resolve uncertainty? When should risk be reassessed? Your plan should explain the reasoning, not simply assign a label.
Use the official calculator with your clinician
AthenaVita's MRS PREVENT assessment is a separate project. It should not be confused with the AHA equations or presented as a validated cardiovascular prediction score.
“What changes because of this estimate?”
Ask how the result shapes your prevention priorities and follow-up.